好消息！3-17岁可打的新冠疫苗来了
<p style="max-width: 100%; min-height: 1em; letter-spacing: 0.544px; white-space: normal; font-family: -apple-system-font, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; background-color: rgb(255, 255, 255); text-align: left; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; letter-spacing: 0.544px; widows: 1;"> 7月16日，中国生物官方微信公号消息，经国务院联防联控机制有关部门组织论证，国药集团中国生物北京生物制品研究所新冠病毒灭活疫苗获批在3-17岁人群中紧急使用。</span><span style="font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; letter-spacing: 0.544px; widows: 1; max-width: 100%; color: rgb(123, 12, 0); box-sizing: border-box !important; overflow-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;">中国新冠灭活疫苗正式获批在该年龄段开展紧急使用。</strong></span></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p><p style="max-width: 100%; min-height: 1em; font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; letter-spacing: 0.544px; line-height: 27.2px; white-space: normal; widows: 1; background-color: rgb(255, 255, 255); box-sizing: border-box !important; overflow-wrap: break-word !important; text-align: center;"></p><p style="max-width: 100%; min-height: 1em; font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; letter-spacing: 0.544px; line-height: 27.2px; white-space: normal; widows: 1; background-color: rgb(255, 255, 255); box-sizing: border-box !important; overflow-wrap: break-word !important; text-align: center;"><span style="max-width: 100%;font-size: 14px;color: rgb(136, 136, 136);box-sizing: border-box !important;overflow-wrap: break-word !important;">图片来源：“中国生物”微信公号</span><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"> 目前，国药集团中国生物新冠疫苗3-17岁年龄组已经在河南完成I/II期临床试验。3-17岁人群免后中和抗体阳转率为100%，中和抗体GMT和阳转率与成人组相比无显著性差异。</p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"> 国药集团中国生物首席科学家、副总裁张云涛说，从观察的数据来看，疫苗安全性数据是符合预期要求的，是比较好的。跟成人组相比没有增加安全性的风险。从免疫原性来看，跟成人组和老年人组相比也是符合要求的，所以I/II期临床研究过程中形成的数据，证明了疫苗可以在3-17岁这个年龄段使用。</p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p><p><br/></p><section powered-by="xiumi.us" style="max-width: 100%;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><p style="max-width: 100%;min-height: 1em;box-sizing: border-box !important;overflow-wrap: break-word !important;"> 张云涛表示，儿童、青少年是免疫屏障构筑的重点人群，而疫苗的安全性又是这类人群临床试验中考虑的重中之重，这也是为什么3-17岁年龄段新冠疫苗“压轴”使用的原因。青少年在生长发育时期，3-17岁人群有免疫系统逐渐完善的一个过程。只有疫苗安全和有效性在成人和老年人验证后，才考虑向儿童和青少年推广，这种做法其实是一个负责任的态度。国外的疫苗厂家也是采用这种技术路线来做的。</p><section powered-by="xiumi.us" style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section powered-by="xiumi.us" style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><p style="max-width: 100%;min-height: 1em;box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p></section></section></section><section powered-by="xiumi.us" style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section style="max-width: 100%;text-align: center;box-sizing: border-box !important;overflow-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(0, 122, 170);font-size: 18px;box-sizing: border-box !important;overflow-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;">3-17岁人群接种新冠疫苗</strong></span></section><section style="max-width: 100%;text-align: center;box-sizing: border-box !important;overflow-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(0, 122, 170);font-size: 18px;box-sizing: border-box !important;overflow-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;">需要注意些什么？</strong></span><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></section><section style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></section></section></section><p><br/></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"> 张云涛表示，<span style="max-width: 100%;color: rgb(123, 12, 0);box-sizing: border-box !important;overflow-wrap: break-word !important;"><strong style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;">总体来说3-17岁年龄段注射新冠疫苗的要求和18岁以上年龄段注射疫苗的要求的说明书是完全相同的。比如有16个谨慎使用等，这个年龄段的人群正常按说明书要求使用就可以。</strong></span>“只要符合要求，我觉得都可以接种，没有什么特殊的一些要求。”</p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><br style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"/></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"> 这次国药集团中国生物北京生物制品研究所新冠病毒灭活疫苗获批的还只是在3-17岁人群中紧急使用，张云涛说，预计一年后，该疫苗有望正式上市。</p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><br/></p><p style="max-width: 100%;min-height: 1em;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;white-space: normal;widows: 1;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><span style="letter-spacing: 0.544px; max-width: 100%; box-sizing: border-box !important; overflow-wrap: break-word !important;"><span style="max-width: 100%;font-family: -apple-system-font, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;letter-spacing: 1.5px;font-size: 14px;box-sizing: border-box !important;overflow-wrap: break-word !important;">内容来源</span></span><span style="max-width: 100%; font-family: -apple-system-font, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif; letter-spacing: 1.5px; font-size: 14px; box-sizing: border-box !important; overflow-wrap: break-word !important;">新华社、中央广电总台中国之声、“中国生物”微信公号</span><br/></p><p><br/></p><section data-tplid="102391" data-tools="135编辑器" style="max-width: 100%;font-family: -apple-system, BlinkMacSystemFont, Helvetica Neue, PingFang SC, Hiragino Sans GB, Microsoft YaHei UI, Microsoft YaHei, Arial, sans-serif;letter-spacing: 0.544px;white-space: normal;background-color: rgb(255, 255, 255);box-sizing: border-box !important;overflow-wrap: break-word !important;"><section data-role="layout" style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section data-role="layout" data-width="100%" style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section data-role="layout-inner" style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section style="max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;"><section style="max-width: 100%;text-align: left;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;widows: 1;box-sizing: border-box !important;overflow-wrap: break-word !important;"><span style="max-width: 100%;color: rgb(0, 0, 0);font-family: Optima-Regular, PingFangTC-light;letter-spacing: 0.544px;font-size: 14px;box-sizing: border-box !important;overflow-wrap: break-word !important;"></span></section><section style="max-width: 100%;font-variant-numeric: normal;font-variant-east-asian: normal;letter-spacing: 0.544px;line-height: 27.2px;widows: 1;box-sizing: border-box !important;overflow-wrap: break-word !important;"><br/></section></section></section></section></section></section></section></section><p><br/></p><link rel="stylesheet" href="http://www.320924.com/source/plugin/wcn_editor/public/wcn_editor_fit.css?v134_DS9" id="wcn_editor_css"/>
页:
[1]